Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • China's new ban on...

    China's new ban on fentanyl-related substances will be a game-changer; says Trump

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-06-03T09:15:49+05:30  |  Updated On 3 Jun 2019 9:15 AM IST
    Chinas new ban on fentanyl-related substances will be a game-changer; says Trump

    Under pressure from Trump, China on May 1 banned all chemical analogues of fentanyl, the synthetic drug at the heart of an overdose epidemic that is killing tens of thousands of people a year in the United States.


    U.S: President Donald Trump says China's new ban on all fentanyl-related substances will be a "game-changer" in the deadly US opioid crisis, but experts warn it may just shift production elsewhere -- particularly Mexico.


    Under pressure from Trump, China on May 1 banned all chemical analogues of fentanyl, the synthetic drug at the heart of an overdose epidemic that is killing tens of thousands of people a year in the United States.


    Trump won the fentanyl concession as part of his trade war with China, which is allegedly the world's leading supplier of the powerful narcotic, along with designer drugs that mimic it and the precursor chemicals used to make all of them.


    But law enforcement officials and anti-narcotics experts warn the ban will probably just push production to other countries -- including the United States' southern neighbour, whose powerful drug cartels are already deeply immersed in fentanyl trafficking.


    Blame it on the "balloon effect", the idea that banning a drug is like trying to squeeze the air out of a balloon: it just moves somewhere else.


    The US Drug Enforcement Administration (DEA) is preparing for exactly that possibility.


    Read Also: Tech firms tackle opioid crisis with software


    "It's a balloon effect.... As we put more pressure on China, they'll just send the chemicals over to Mexico to make (fentanyl) there," a DEA official told AFP, speaking on condition of anonymity.


    Chinese suppliers will now likely start shipping "pre-precursors" abroad to get around the ban, he said.


    So many different substances can be used to make fentanyl, and the Chinese chemicals industry is so massive, that it will be impossible to regulate every potential source of the drug, he added.


    "They'll figure out how to go generate two or three (chemicals) to replace the one we just put controls on," he said.


    "It's great that they did that, but a chemist can go back to what is uncontrolled, work that up to the precursor they need, and make fentanyl."


    The balloon effect is what pushed narcotics production to China in the first place, experts say.


    Responding to a crystal meth boom in the United States around the turn of the millennium, authorities imposed tougher controls on cough syrups and other legal medications used to "cook" the drug.


    Read Also: Trump to keep fighting opioids ‘until our job is done’


    The new regulations hit American meth labs hard. But they gave Mexican cartels a new line of business -- leading them to develop connections with the chemical industry in China, which supplied them precursors for meth.


    Then, the opioid epidemic began to take hold in the United States, rooted in decades of over-prescription of addictive painkillers.


    That led to tighter controls on prescription narcotics such as OxyContin, and so Chinese suppliers expanded into making fentanyl -- a potent narcotic up to 100 times stronger than morphine that has killed thousands of people in the US, including celebrity overdose victims Tom Petty and Prince.


    Soon, Mexican cartels were trafficking counterfeit pain pills into the United States made with Chinese fentanyl.


    With the Chinese ban now in place, Mexican criminal groups such as the Sinaloa and Jalisco New Generation cartels, whose current role in the production is limited, have an incentive to onshore more of the fentanyl supply chain, said Edgardo Buscaglia, an organized crime expert at Columbia University.


    "The Chinese ban will clearly create an effect where smaller suppliers, including Mexico, scale up production to satisfy demand. That's how markets work," he said.


    "Production will also expand in Pakistan, India, North Korea," he added.


    But "Mexico, in particular, has a very serious problem regulating its pharmaceutical industry," he said. "And it's an enormous, enormous market. So it's very possible fentanyl production will increase in Mexico with the criminal structures that already exist.

    Amid fentanylchinachina marketcrystal methDEAdrugsfentanylfentanyl traffickingMexicoopioidOxyContinpainkillerspioid epidemic in the United Statessynthetic drugTrump. Donald TrumpUnited StatesUS Drug Enforcement AdministrationUS opioid crisis
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok